Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Serra Automotive Ranked First in 2024 Dealer Group Study for Providing Quick and Easy Service Appointments
-
Race Communications Announces New Capital Raise to Accelerate California Expansion
-
OKX Explorer Enhances Bitcoin Ecosystem Coverage with Fractal Integration
-
Cortux Unveils Innovative DeFi and E-Commerce Ecosystem with CRX Token
-
My Heart My Love Gifts Celebrates Milestone Award
-
LifeWallet Launches Initiative to Secure New Agreements with Health Plans, Providers, Insurers and Attorneys, Continues Cost Cutting Efforts, and Announces it Secured a Waiver of Acceleration Based on
-
Statement regarding investigation of alleged misconduct
-
CenterPoint Energy Remains Vigilant and Prepared for Storm Response as Tropical Activity in the Gulf of Mexico Continues to Strengthen
-
Aura Minerals Inc.: Almas Production Preview - July and August 2024
-
Aura Minerals Inc.: Notice to the Market
-
Senhwa Biosciences Presents Clinical Data Abstract on Pidnarulex at 2024 ESMO Congress
-
SANY Heavy Industry Reports Strong Half-Year Results
-
Pelangio Exploration Announces Private Placement for Gross Proceeds Up To $400,000
-
HEKA, the Inventor of AI Mattress, Launches the Sixth-Generation AI Mattress, Ushering in a New Era of Healthy Sleep
-
Methanex Corporation Signs Definitive Agreement to Acquire OCI Global’s International Methanol Business for $2.05 Billion
-
MedTech Innovator Asia Pacific Names APrevent Top 2024 Innovator in Grand Finals Competition
-
Nick Pollard Joins CAIA Association as Managing Director of Asia Pacific
-
JST Digital Obtains In-Principle Approval for a Major Payment Institution Licence from Monetary Authority of Singapore
-
OCI Global Announces Agreement for the Sale of its Global Methanol Business to Methanex
-
SalesNow Announces the 2024 Japan Startup Growth Companies Ranking TOP 100
-
Antennova to Present Latest Data of ATN-037 in a Mini Oral Presentation at ESMO Congress 2024
-
ESMO 2024 | Ascentage Pharma to Present Updated Data of Olverembatinib in Patients with SDH-Deficient GIST during a Mini Oral Presentation at the 2024 ESMO Congress
-
Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival
-
MeeTion Launched The GW32 - The Ultimate Right-Handed Ergonomic Gaming Mouse
-
MeeTion Launched The Next-Gen BTH011 Gaming Headset For Superior Performance
-
Akwaaba App Expands in Ghana, Launches New Features for Businesses and Influencers
-
5 Effective Strategies to Foster Positive Connections with Children on the Autism Spectrum
-
Planning Your Move from Florida to California: A Comprehensive Guide
-
Eisai to Present E7386, co-created by PRISM BioLab and Eisai, at the ESMO (European Society for Medical Oncology) Annual Meeting
-
Teledyne FLIR Delivering Airborne Surveillance Systems to Japan Maritime Self-Defense Force Worth Up to $21 Million
-
HUTCHMED Highlights Clinical Data to be Presented at ESMO Congress 2024 and the 2024 World Conference of Lung Cancer
-
Hoonigan Signs Asset Purchase Agreement to Divest 4 Wheel Parts’ Retail Stores and Associated E-Commerce Assets to ARB Corporation’s U.S. Affiliate, ORW USA
-
Hoonigan Announces Strategic Transaction to Strengthen Financial Foundation and Support Long-Term Growth
-
Collaboration between China, Africa helps foster a more just global order
-
Toshiba Unveils the High-End Masterstroke Series at IFA 2024, Showcasing a New Era of Masterpiece Appliances
-
The 2024 Global Energy Transition Conference Kicks Off in Beijing's Future Science City
-
Saudi Arabia's landmark Global AI Summit to address harnessing AI for the good of humanity
-
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
-
What’s New with Personio: Improved people insights, performance reviews and custom workflows drive impact for HR teams
-
NOVONIX Announces Participation in the H.C. Wainwright Conference
-
ALIMENTATION COUCHE-TARD COMMENTS ON SEVEN & I HOLDINGS' RESPONSE NOT TO ENGAGE IN FRIENDLY DISCUSSIONS REGARDING A VALUE CREATING COMBINATION
-
Cantargia: New Data from Two Clinical Studies Strongly Support Nadunolimab Efficacy After Relapse on PD1-Inhibitors
-
Ultimovacs Announces Updated Data Analysis on UV1 Phase II NIPU Trial in Mesothelioma at ESMO 2024
-
C4 Therapeutics to Present Preliminary CFT1946 Monotherapy Phase 1 Clinical Data at the European Society for Medical Oncology (ESMO) Congress 2024
-
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
-
Resecurity Partners with Mannai Trading Corporation to Bolster Cybersecurity in Qatar
-
ICEYE to deliver SAR satellites and data to Greece's National Satellite Space Project in collaboration with the European Space Agency
-
Perioperative Ivonescimab (PD-1/VEGF) for NSCLC Demonstrated Clinically Significant Phase II Results, Presented in Oral Session at WCLC 2024
-
LinkBuilder.io Analyzes Impact of Google's SpamBrain Link Update
-
Government Leaders to Detail Patient Harm Prevention Efforts at World Patient Safety Day Summit
